Trial intelligence / Profile preview

Paravertebral block for analgesia in lower limb-sparing cancer surgery

NCT04396561Phase 4Completed

Sponsor
Cairo University
Start
Jan 2020
Primary completion
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Total intraoperative fentanyl consumption at 24 hours. Started Jan 2020; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04396561.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04396561.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call